Drug Profile
Research programme: glial excitotoxin release inhibitors - Questcor
Alternative Names: GERI compounds - Questcor; Glial excitotoxin release inhibitors research programme - QuestcorLatest Information Update: 17 Oct 2005
Price :
$50
*
At a glance
- Originator Questcor Pharmaceuticals
- Class
- Mechanism of Action Glial excitotoxin release inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cerebral ischaemia; Stroke
Most Recent Events
- 13 Oct 2005 Discontinued - Preclinical for Cerebral ischaemia in USA (unspecified route)
- 13 Oct 2005 Discontinued - Preclinical for Stroke in USA (unspecified route)
- 05 Mar 2002 Preclinical trials in Cerebral ischaemia in USA